Next-Generation Blood Pumps

Publication ID: 24-11857777_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Blood Pumps,” Published Technical Disclosure No. 24-11857777_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857777_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,777.

Summary of the Inventive Concept

A revolutionary, miniaturized, and implantable blood pump system that wirelessly harnesses external energy and adapts to individual circulatory needs, enabling personalized, long-term circulatory support.

Background and Problem Solved

The original patent disclosed blood pumps with limitations in size, power supply, and adaptability to individual patients. The next-generation blood pumps address these limitations by introducing miniaturized, implantable, and wirelessly powered pump modules that adapt to a patient's anatomy and circulatory needs.

Detailed Description of the Inventive Concept

The inventive concept comprises a miniaturized, implantable pump module that is powered wirelessly through inductive coupling with an external energy source. This enables long-term implantation within a patient's circulatory system. The pump module features a self-sustaining, bio-inspired propulsion mechanism that mimics the natural pumping action of the heart, minimizing energy consumption and maximizing circulatory support. Additionally, the system incorporates a closed-loop control mechanism that utilizes real-time, AI-driven monitoring of a patient's hemodynamic parameters to optimize pump performance and ensure personalized, adaptive circulatory support.

Novelty and Inventive Step

The inventive concept's novelty lies in its miniaturized, implantable, and wirelessly powered design, which enables long-term implantation and personalized circulatory support. The inventive step is the integration of bio-inspired propulsion mechanisms and AI-driven control systems, which revolutionize the field of blood pumps.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept include swarm-based micro-pumps, wearable, non-invasive blood pump devices, and flexible, conformable pump elements driven by artificial muscle technology. These variations ensure broad conceptual coverage and adaptability to diverse patient needs.

Potential Commercial Applications and Market

The next-generation blood pumps have vast commercial potential in the medical device industry, targeting applications in cardiac assist devices, mechanical circulatory support, and personalized medicine. The market for these devices is expected to grow significantly, driven by the increasing demand for minimally invasive, long-term circulatory support solutions.

Field of Art

Biomedical engineering, specifically cardiac assist devices and mechanical circulatory support systems, requiring advanced knowledge of fluid dynamics, medical device design, and cardiovascular physiology

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in implantable medical devices, fluid mechanics, wireless power transfer, and advanced control systems, typically holding a PhD or equivalent professional experience in medical device innovation

Obviousness Rationale

A PHOSITA would recognize that the PTD's wireless power, miniaturization, and adaptive control strategies represent predictable technological extensions of existing blood pump technologies. The core functional requirements of blood pumps - minimally invasive deployment, efficient blood flow management, and sustained performance - remain consistent with the source patent's teachings. The proposed variations demonstrate incremental improvements using known engineering techniques and emerging technologies readily available to skilled practitioners.

Obvious Combinations & Variations

Source Patent Element
Percutaneously deliverable impeller assembly with rotor system
PTD Variation
Miniaturized, wirelessly powered implantable pump module with inductive coupling
Obviousness Reasoning
Miniaturization and wireless power transfer are predictable design improvements for implantable medical devices, representing a known technique for enhancing patient comfort and device longevity
Source Patent Element
Blood vessel wall engagement mechanisms using expandable struts
PTD Variation
Swarm-based micro-pumps deployed within bloodstream to augment regional blood flow
Obviousness Reasoning
Distributed deployment strategies are a logical extension of existing localized blood flow management techniques, representing a finite set of design solutions for circulatory support
Source Patent Element
Rotor assembly with impeller shaft and sleeve bearing
PTD Variation
Bio-inspired propulsion mechanism mimicking natural heart pumping action
Obviousness Reasoning
Biomimetic design approaches are well-established in medical device engineering, representing a predictable method of optimizing device performance based on physiological models
Source Patent Element
Method of operating blood flow assist system
PTD Variation
AI-driven closed-loop control system monitoring hemodynamic parameters
Obviousness Reasoning
Integration of real-time monitoring and adaptive control represents a standard engineering approach to improving medical device performance, utilizing known machine learning and sensor technologies
Source Patent Element
Percutaneous delivery of impeller assembly
PTD Variation
Wearable, non-invasive blood pump with flexible, conformable pump element
Obviousness Reasoning
Alternative form factors for medical devices are a predictable design evolution, representing a known technique for improving patient interface and device versatility
35 U.S.C. § 103 Summary: Pursuant to 35 U.S.C. ยง 103, the variations disclosed in the published technical disclosure would have been obvious to a person having ordinary skill in the art at the time of invention, when considered in light of US Patent 11857777. The incremental technological improvements represent predictable extensions of existing blood pump technologies, employing known engineering techniques and emerging medical device design strategies to enhance circulatory support systems.

Original Patent Information

Patent NumberUS 11,857,777
TitleBlood pumps
Assignee(s)Procyrion, Inc.